Comprising 26 chapters, this volume deals with the genetic transformation of medicinal plants. It describes methods to obtain plants resistant to insects, diseases, herbicides, and plants with an increased production of compounds of medicinal and pharmaceutical importance. The plant species included are Ajuga reptans, Anthemis nobilis, Astragalus spp., Atropa belladonna, Catharanthus roseus, Datura spp., Duboisia leichhardtii, Fagopyrum spp., Glycyrrhiza uralensis, Lobelia spp., Papaver somniferum, Panax ginseng, Peganum hamala, Perezia spp., Pimpinella anisum, Phyllanthus niruri, Salvia miltiorrhiza, Scoparia dulcis, Scutellaria baicalesis, Serratula tinctoria, Solanum aculeatissimum, Solanum commersonii, Swainsona galegifolia, tobacco, and Vinca minor. The book is of special interest to advanced students, teachers, and researchers in the fields of pharmacy, plant tissue culture, phytochemistry, molecular biology, biomedical engineering, and plant biotechnology in general.

In applying ancient Hebrew maxims to the revolution in plant biotechnology, Esra Galun (Weizmann Institute of Science, Israel) and Eithan Galun (Hadassah U. Hospital) contend that motivation in this field may stem as much from the prospect of being a creator of something new as from producing valuable medical products. They cover the fundamentals of plant molecular genetics and genetic transformations prior to discussing the relation of transgenic "plantibodies" to immunology and therapeutic products unrelated to the immune system. Further considerations include research gaps and safety issues. Distributed in the US by World Scientific. c. Book News Inc.

Transgenic Technology Based Value Addition in Plant Biotechnology discusses the principles, methodology and applications of transgenic technologies. With step-by-step methods on genome editing techniques and a range of potential applications, from improving crop yield to increasing therapeutic efficacy, this book is a one-stop reference for plant gene editing technologies. It will be of particular interest to researchers interested in plant biotechnology and plant genetics, as well as agricultural scientists and those concerned with medicinal plants. - Includes step-by-step methods to assist students and researchers with genome editing and bioinformatics tools - Highlights a number of applications of plant biotechnology, including how to achieve desired traits, such as improved crop yield - Discusses principles, methodology and applications of transgenic technologies

Assists policymakers in evaluating the appropriate scientific methods for detecting unintended changes in food and assessing the potential for adverse health effects from genetically modified products. In this book, the committee recommended that greater scrutiny should be given to foods containing new compounds or unusual amounts of naturally occurring substances, regardless of the method used to create them. The book offers a framework to guide federal agencies in selecting the route of safety assessment. It identifies and recommends several pre- and post-market approaches to guide the assessment of unintended compositional changes that could result from genetically modified foods and research avenues to fill the knowledge gaps.

Covering the latest advances in the use of plants to produce medicinal drugs and vaccines, examines topics including plant tissue culture, secondary metabolite production, metabolomics and metabolic engineering, bioinformatics, molecular farming and future biotechnological directions.

This volume, Transgenic Crops VI, includes the following broad topic sections: Oils and Fibers, Medicinal Crops, Ornamental Crops, Forages and Grains, Regulatory and Intellectual Property of Genetically Manipulated Plants. It is an invaluable reference for plant breeders, researchers and graduate students in the fields of plant biotechnology, agronomy, horticulture, forestry, genetics, and both plant cell and molecular biology.